Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
From KRASG12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design.
Journal: Journal of medicinal chemistry
Published: April 09, 2026
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2.
Journal: Journal of medicinal chemistry
Published: August 13, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction.
Journal: Journal of medicinal chemistry
Published: March 24, 2021
Fragment-based drug discovery and its application to challenging drug targets.
Journal: Essays in biochemistry
Published: July 11, 2017
Showing 1-4 of 4
Last Updated: 09/26/2026